MAT book-profit adjustments exclude disallowances for exempt-income expenditure and demerger expenditure unless expressly listed under the statutory c...
Omitted specified domestic transaction provision invalidates related-party expenditure transfer-pricing references and assessments based on consequent...
Preventive suspension requires an immediate continuing threat and cannot become indefinite without inquiry, fresh evidence, or proportionate safeguard...
SC rejected the petition challenging the show cause notice under Section 124 of the Customs Act, 1962 regarding pharmaceutical raw materials export. The Court directed the DGFT to review the petitioner's representations and make an appropriate determination. The authority was instructed to proceed with adjudication after DGFT's decision. The court found the show cause notice process appeared procedurally valid, with no substantive response provided by the petitioner. The petition was disposed of, effectively allowing administrative reconsideration of the classification and export documentation.
SC rejected the petition challenging the show cause notice under Section 124 of the Customs Act, 1962 regarding pharmaceutical raw materials export. The Court directed the DGFT to review the petitioner's representations and make an appropriate determination. The authority was instructed to proceed with adjudication after DGFT's decision. The court found the show cause notice process appeared procedurally valid, with no substantive response provided by the petitioner. The petition was disposed of, effectively allowing administrative reconsideration of the classification and export documentation.
Note: It is a system-generated summary and is for quick reference only.